Browsing ODA Open Digital Archive by Author "Solli, Kristin Klemmetsby"
Now showing items 1-12 of 12
-
Adapting treatment length to opioid-dependent individuals' needs and preferences: A 2-year follow-up to a 1-year study of extended-release naltrexone
Solli, Kristin Klemmetsby; Opheim, Arild; Latif, Zill-E-Huma; Krajci, Peter; Saltyte Benth, Jurate; Kunoe, Nikolaj; Tanum, Lars Håkon Reiestad (Addiction;, Journal article; Peer reviewed, 2020-12-18)Background and aim: Extended-release naltrexone (XR-NTX) is an underused treatment option for opioid dependence, today only available in a few countries in the world. Although effective, safe and feasible in short-term ... -
Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial
Solli, Kristin Klemmetsby; Kunøe, Nikolaj; Latif, Zill-E-Huma; Haase, Kamni Sharma; Opheim, Arild; Krajci, Peter; Gaulen, Zhanna; Saltyte Benth, Jurate; Tanum, Lars Håkon Reiestad (European Addiction Research;2019, Vol. 25, No. 6, Journal article; Peer reviewed, 2019-07-19)Background and objective: Opioid maintenance treatment (OMT) is highly available in Norway, but only 50% of opioid-dependent individuals are enrolled in such programs. This study was aimed at examining if availability of ... -
Chronic Pain Among Patients With an Opioid Use Disorder
Latif, Zill-E-Huma; Skjærvø, Ingeborg; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (American Journal on Addictions;, Peer reviewed; Journal article, 2021-03-19)Background and objectives: Chronic pain is not well understood in opioid-dependent populations. We report the prevalence of chronic pain and pain characteristics in an opioid-dependent population by treatment type and ... -
Discrepancy in Ratings of Shared Decision Making Between Patients and Health Professionals: A Cross Sectional Study in Mental Health Care
Drivenes, Karin; Haaland, Vegard Øksendal; Hauge, Yina L.; Vederhus, John-Kåre; Irgens, Audun Campbell; Solli, Kristin Klemmetsby; Regevik, Hilde; Falk, Ragnhild Sørum; Tanum, Lars Håkon Reiestad (Frontiers in Psychology;Volume 11, Journal article; Peer reviewed, 2020-03-24)Background: A defined goal in mental health care is to increase the opportunities for patients to more actively participate in their treatment. This goal includes integrating aspects of user empowerment and shared decision-making ... -
Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
Weimand, Bente; Solli, Kristin Klemmetsby; Wenche Helleren, Reichelt; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2021)Opioid-dependence is a comprehensive, relapsing disorder with negative individual, - family, - and societal consequences. Recovery is difficult to achieve. Research has shown reduced substance use and improved healthand ... -
Enablers and hindrances for longer-term abstinence in opioid dependent individuals receiving treatment with extended-release naltrexone: A Norwegian longitudinal recovery trial (NaltRec study)
Weimand, Bente; Solli, Kristin Klemmetsby; Reichelt, Wenche Helleren; Tanum, Lars (Contemporary Clinical Trials Communications;volume 21, Peer reviewed; Journal article, 2021-02-10)Opioid-dependence is a comprehensive, relapsing disorder with negative individual, - family, - and societal consequences. Recovery is difficult to achieve. Research has shown reduced substance use and improved healthand ... -
Levels of impulsivity, hyperactivity, and inattention and the association with mental health and substance use severity in opioid-dependent patients seeking treatment with extended-release naltrexone
Karlsson, Ann Tarja; Vederhus, John-Kåre; Clausen, Thomas; Weimand, Bente; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad (Journal of Clinical Medicine;Volume 10 / Issue 19, Peer reviewed; Journal article, 2021-09-30)The level of impulsivity, hyperactivity, and inattention (IHI) is higher among patients with substance use disorder (SUD) than in the general population. However, the prevalence of such symptoms in patients seeking treatment ... -
Not at all what I had expected: Discontinuing treatment with extended-release naltrexone (XR-NTX): A qualitative study
Brenna, Ida Halvorsen; Marciuch, Anne; Birkeland, Bente; Veseth, Marius; Røstad, Bente; Løberg, Else-Marie; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Weimand, Bente (Peer reviewed; Journal article, 2021)Background: Extended-release naltrexone (XR-NTX), an opioid antagonist, has demonstrated equal treatment outcomes, in terms of safety, opioid use, and retention, to the recommended OMT medication buprenorphine. However, ... -
Patients with Opioid Use Disorder Choosing Treatment with Extended-Release Naltrexone: A 6-Month Naturalistic Study
Brenna, Ida Halvorsen; Waleur, Karin Merethe; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Mordal, Jon; Løberg, Else-Marie; Weimand, Bente; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2024)Introduction: The treatment efficacy of extended-release naltrexone (XR-NTX) for opioid use disorder (OUD) has been demonstrated in several studies, but not in naturalistic settings where opioid agonist treatment (OAT) is ... -
Personal recovery among people with opioid use disorder during treatment with extended-release naltrexone
Marciuch, Anne; Birkeland, Bente; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Tanum, Lars Håkon Reiestad; Mathisen, Ida; Weimand, Bente (Peer reviewed; Journal article, 2023)Background and aims Recovery from substance use disorders (SUD) has traditionally been equated with abstinence. “Personal recovery” however emphasizes recovery as a unique and personal process, supported by changes in ... -
Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial
Opheim, Arild; Gaulen, Zhanna; Solli, Kristin Klemmetsby; Latif, Zill-E-Huma; Fadnes, Lars T.; Saltyte Benth, Jurate; Kunøe, Nikolaj; Tanum, Lars Håkon Reiestad (American Journal on Addictions;Volume 30, Issue 5, September 2021, Peer reviewed; Journal article, 2021-09-06)Background and Objectives: Compare the risk of relapse to heroin and other illicit opioids among opioid‐dependent patients receiving treatment with extended‐release naltrexone (XR‐NTX) or buprenorphine‐naloxone (BP‐NLX). ... -
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial
Opheim, Arild; Saltyte Benth, Jurate; Solli, Kristin Klemmetsby; Kloster, Pia Synnøve; Fadnes, Lars T.; Kunøe, Nikolaj; Gaulen, Zhanna; Tanum, Lars Håkon Reiestad (Peer reviewed; Journal article, 2023)ackground and objective: First study to assess any compensatory increase in use of non-opioid illicit substances and alcohol in opioid dependent patients randomized to treatment with extended-release naltrexone (XR-NTX) ...